Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The formulation is compounded by a licensed pharmacy and administered intramuscularly or subcutaneously, typically 0.5-1 mL weekly
Researchers interested in peptide purity testing, HPLC peptide analysis, LC-MS verification, laboratory handling, storage recommendations, and peptide quality control can browse our Research Peptide Guides
Common injection sites: For Intramuscular (IM): Upper arm (deltoid) Outer thigh (vastus lateralis) often the easiest self-injection site Upper outer gluteal muscle usually requires assistance For Subcutaneous (SQ): Abdomen (at least 12 inches away from the navel) Outer thigh Back of the upper arm What are the side effects
FDA added dysesthesia to injectable semaglutide labeling, January 2025
When rats with GIF were treated with BPC-157 once a day, the fistulas were fully healed and closed up after 46 days of administering the peptide [10]
Risk mitigation
US$ 28.56
US$ 22.24
US$ 26.01
